Figure S5: GDD-ENS Performance Across Purity Values from Deep-Learning Model for Tumor-Type Prediction Using Targeted Clinical Genomic Sequencing Data

Assessment of GDD-ENS performance on the test set across reported purity values, binned in 10% increments. Count of each bin (top), and corresponding overall accuracy (light pink), and high-confidence accuracy (dark pink). Samples with NA purity values or >90% were removed, representing only 106 samples total.